Chen BK - Search Results

1

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.

Bennett CL, Schoen MW, Hoque S, Witherspoon BJ, Aboulafia DM, Hwang CS, Ray P, Yarnold PR, Chen BK, Schooley B, Taylor MA, Wyatt MD, Hrushesky WJ, Yang YT. Bennett CL, et al. Among authors: chen bk. Lancet Oncol. 2020 Dec;21(12):e575-e588. doi: 10.1016/S1470-2045(20)30485-X. Lancet Oncol. 2020. PMID: 33271114 Review.

2

Post-marketing surveillance of prescription drug safety: past, present, and future.

Chen BK, Yang YT. Chen BK, et al. J Leg Med. 2013;34(2):193-213. doi: 10.1080/01947648.2013.800797. J Leg Med. 2013. PMID: 23980746 No abstract available.

3

Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive Analysis.

Chen BK, Yang YT, Cheng X, Bian J, Bennett CL. Chen BK, et al. PLoS One. 2016 May 12;11(5):e0155259. doi: 10.1371/journal.pone.0155259. eCollection 2016. PLoS One. 2016. PMID: 27171162 Free PMC article.

4

Generic oncology drugs: are they all safe?

Yang YT, Nagai S, Chen BK, Qureshi ZP, Lebby AA, Kessler S, Georgantopoulos P, Raisch DW, Sartor O, Hermanson T, Kane RC, Hrushesky WJ, Riente JJ, Norris LB, Bobolts LR, Armitage JO, Bennett CL. Yang YT, et al. Among authors: chen bk. Lancet Oncol. 2016 Nov;17(11):e493-e501. doi: 10.1016/S1470-2045(16)30384-9. Lancet Oncol. 2016. PMID: 27819247 Review.

5

Trends in amenable deaths based on township income quartiles in Taiwan, 1971-2008: did universal health insurance close the gap?

Chen BK, Yang YT, Yang CY. Chen BK, et al. J Public Health (Oxf). 2016 Dec 2;38(4):e524-e536. doi: 10.1093/pubmed/fdv156. J Public Health (Oxf). 2016. PMID: 28158683 No abstract available.

6

Generic drugs in oncology - Authors' reply.

Bennett CL, Nagai S, Yang YT, Chen BK, Sartor O, Armitage JO. Bennett CL, et al. Among authors: chen bk. Lancet Oncol. 2017 Feb;18(2):e64. doi: 10.1016/S1470-2045(17)30016-5. Lancet Oncol. 2017. PMID: 28214418 No abstract available.

7

Patient Copayments, Provider Incentives and Income Effects: Theory and Evidence from the Essential Medications List under China's 2009 Healthcare Reform.

Chen BK, Yang YT, Eggleston K. Chen BK, et al. World Med Health Policy. 2017 Mar;9(1):24-44. doi: 10.1002/wmh3.222. Epub 2017 Mar 16. World Med Health Policy. 2017. PMID: 29075552 Free PMC article.

8

Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition.

Chen BK, Yang YT, Bennett CL. Chen BK, et al. Drugs. 2018 Nov;78(17):1777-1781. doi: 10.1007/s40265-018-1009-0. Drugs. 2018. PMID: 30446980

9

Early evidence from South Carolina's Medicare-Medicaid dual-eligible financial alignment initiative: an observational study to understand who enrolled, and whether the program improved health?

Chen BK, Yang YT, Gajadhar R. Chen BK, et al. BMC Health Serv Res. 2018 Nov 29;18(1):913. doi: 10.1186/s12913-018-3721-6. BMC Health Serv Res. 2018. PMID: 30497468 Free PMC article.

10

Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.

Bennett CL, Schooley B, Taylor MA, Witherspoon BJ, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Young T, Knopf KB, Chen B. Bennett CL, et al. PLoS One. 2019 Jul 31;14(7):e0219521. doi: 10.1371/journal.pone.0219521. eCollection 2019. PLoS One. 2019. PMID: 31365527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page